PTP4A3 and breast carcinoma: PRL-3 also caused cell cycle arrest in estrogen receptor (ER)-positive breast cancer cell lines, indicating the need for more experiments to confirm PRL-3 as a modulator of cellular dynamics in ER+ breast cancer [66].